Lai Jin Selected Research

Urocortins

11/2016	UCN enhances TGF-beta-mediated mitoinhibition of VSMCs via counteracting TGF-beta-induced cPLA2 expression and activation.
11/2015	Urocortin attenuates TGFβ1-induced Snail1 and slug expressions: inhibitory role of Smad7 in Smad2/3 signaling in breast cancer cells.
5/2014	Urocortin affects migration of hepatic cancer cell lines via differential regulation of cPLA2 and iPLA2.
2/2014	Urocortin increased endothelial ICAM1 by cPLA2-dependent NF-κB and PKA pathways in HUVECs.
12/2013	Sex difference in urocortin production is contributory to the gender disparity in a rat model of vasculitis induced by sodium laurate.
9/2013	Dihydrotestosterone alters urocortin levels in human umbilical vein endothelial cells.
6/2012	Role of corticotropin-releasing hormone family peptides in androgen receptor and vitamin D receptor expression and translocation in human breast cancer MCF-7 cells.
10/2011	Different effects of corticotropin-releasing factor and urocortin 2 on apoptosis of prostate cancer cells in vitro.
10/2009	Urocortin induced expression of COX-2 and ICAM-1 via corticotrophin-releasing factor type 2 receptor in rat aortic endothelial cells.
8/2009	Urocortin promotes the development of vasculitis in a rat model of thromboangiitis obliterans via corticotrophin-releasing factor type 1 receptors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lai Jin Research Topics

Disease

7	Inflammation (Inflammations) 01/2022 - 10/2012
7	Breast Neoplasms (Breast Cancer) 01/2022 - 06/2012
6	Neoplasms (Cancer) 01/2022 - 02/2010
3	Vasculitis (Vasculitides) 12/2013 - 08/2009
2	Multiple Myeloma 10/2022 - 10/2019
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2020 - 01/2019
2	Stroke (Strokes) 01/2020 - 01/2019
2	Prostatic Neoplasms (Prostate Cancer) 06/2014 - 10/2011
2	Carcinoma (Carcinomatosis) 05/2014 - 04/2014
2	Type 2 Diabetes Mellitus (MODY) 02/2013 - 01/2011
2	Graft vs Host Disease (Graft-Versus-Host Disease) 04/2011 - 04/2010
2	Thromboangiitis Obliterans (Buerger's Disease) 10/2009 - 08/2009
1	Fatigue 01/2022
1	Chest Pain (Chest Pains) 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2022
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022
1	Stomach Neoplasms (Stomach Cancer) 01/2022
1	Brain Edema (Cerebral Edema) 01/2019
1	Infarction (Infarctions) 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2016
1	Colitis-Associated Neoplasms 08/2014
1	Weight Loss (Weight Reduction) 08/2014
1	Colonic Neoplasms (Colon Cancer) 08/2014
1	Carcinogenesis 08/2014
1	Hepatocellular Carcinoma (Hepatoma) 05/2014
1	Liver Neoplasms (Liver Cancer) 05/2014
1	Wounds and Injuries (Trauma) 10/2012
1	Neuroinflammatory Diseases 10/2012
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 02/2010

Drug/Important Bio-Agent (IBA)

10	UrocortinsIBA 11/2016 - 08/2009
7	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2022 - 08/2009
6	Hormones (Hormone)IBA 01/2022 - 02/2014
5	Corticotropin-Releasing Hormone Receptors (Corticotropin Releasing-Hormone Receptor)IBA 01/2019 - 06/2012
3	Corticotropin-Releasing HormoneIBA 04/2014 - 10/2011
3	lauric acid (dodecanoic acid)IBA 12/2013 - 08/2009
2	B-Cell Maturation AntigenIBA 10/2022 - 10/2019
2	Chimeric Antigen ReceptorsIBA 10/2022 - 10/2019
2	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 10/2022 - 10/2019
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2019
2	Coloring Agents (Dyes)IBA 01/2020 - 01/2019
2	Evans Blue (Blue, Evans)FDA Link 01/2020 - 01/2019
2	Phospholipases A2 (Phospholipase A2)IBA 01/2019 - 05/2014
2	Cadherins (E-Cadherin)IBA 11/2015 - 04/2014
2	Transforming Growth Factors (Transforming Growth Factor)IBA 11/2015 - 06/2014
2	Peptides (Polypeptides)IBA 08/2014 - 06/2012
2	HDL LipoproteinsIBA 02/2013 - 01/2011
1	ruxolitinibIBA 01/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Deubiquitinating EnzymesIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Dasatinib (BMS 354825)FDA Link 01/2022
1	Cladribine FDA LinkGeneric 01/2022
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2022
1	MicroRNAs (MicroRNA)IBA 01/2022
1	Ubiquitin-Specific ProteasesIBA 01/2022
1	2- methyl- 4- (N- propyl- N- cycloproanemethylamino)- 5- chloro- 6- (2,4,6- trichloranilino)pyrimidineIBA 01/2020
1	Cytochromes c (Cytochrome c)IBA 01/2020
1	JTE 013IBA 01/2019
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 01/2019
1	Claudin-5IBA 01/2019
1	cadherin 5IBA 01/2019
1	OccludinIBA 01/2019
1	RNA Polymerase II (RNA Polymerase B)IBA 01/2018
1	Transforming Growth Factor beta (TGF-beta)IBA 11/2016
1	Sirtuin 1IBA 04/2016
1	Cocaine (Cocaine HCl)IBA 04/2016
1	Interleukin-6 (Interleukin 6)IBA 08/2014
1	Interleukin-10 (Interleukin 10)IBA 08/2014
1	CytokinesIBA 08/2014
1	CalciumIBA 06/2014
1	Phospholipases (Phospholipase)IBA 06/2014
1	EnzymesIBA 05/2014
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 02/2014
1	Dihydrotestosterone (Androstanolone)IBA 12/2013
1	AndrogensIBA 12/2013
1	LipopolysaccharidesIBA 10/2012
1	Propofol (Diprivan)FDA LinkGeneric 10/2012
1	Androgen Receptors (Androgen Receptor)IBA 06/2012
1	Calcitriol Receptors (Calcitriol Receptor)IBA 06/2012
1	NeuropeptidesIBA 10/2011
1	Glucose (Dextrose)FDA LinkGeneric 01/2011
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2010
1	CRF receptor type 2IBA 02/2010
1	Troleandomycin (TAO)FDA Link 08/2009

Therapy/Procedure

3	Therapeutics 01/2022 - 01/2022
1	Drug Therapy (Chemotherapy) 01/2022
1	Ovariectomy (Oophorectomy) 12/2013
1	Orchiectomy (Orchidectomy) 12/2013
1	Anesthesia 10/2012
1	Transplantation 04/2011
1	Hematopoietic Stem Cell Transplantation 04/2010